Treatment With Saroglitazar Improves NAFLD and Metabolic Outcomes in Liver Transplant Recipients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients
Liver Transpl. 2023 Sep 01;29(9)979-986, MS Siddiqui, D Parmar, F Shaikh, M Forsgren, S Patel, AT Bui, S Boyett, V Patel, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.